NK

Navin Karnani

Active Director Director DIN 06453928
DIN 06453928 First appointment Dec 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Dec 2012
Shareholding value •••• Premium profile

About Navin Karnani

Data last updated:

Navin Karnani is a Director at Deccan Nutraceuticals Private Limited (since 2012), Director at Rjb Estates Private Limited (since 2024) and Director at Markal Industries Association (since 2021), and holds 1 more current directorship. The companies operate in Pharma, Financial Services and Service. The 3 current companies with reported revenue have a combined latest revenue of ₹38.93 Cr; the largest is Deccan Nutraceuticals Private Limited at ₹32.43 Cr (FY 2024). Earlier, Navin Karnani was a Designated Partner at Smnr Exim Llp (2015–2024).

DIN 06453928
Primary Designation Director
Industry Pharma
First Appointment 17 Dec 2012
Oldest Company Age 25 yrs
Largest company Deccan Nutraceuticals Private Limited · ₹32.43 Cr (FY 2024)
Combined revenue ₹38.93 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Dec 20122001₹32.43 Cr (FY 2024)Active
Rjb Estates Private Limited U01100PN2002PTC017221
Director31 Mar 20242002₹6.45 Cr (FY 2025)Active
Markal Industries Association U91110PN2011NPL140746
Director29 Dec 20212011₹4.9 Lakh (FY 2024)Active
Karnani Securities Private Limited U64990PN2025PTC242358
Director24 May 20252025Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Smnr Exim Llp AAD-5875
Designated Partner20 Mar 20152015₹1.59 Cr (FY 2023)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Markal Industries Association
Deccan Nutraceuticals Private Limited
Karnani Securities Private Limited
Rjb Estates Private Limited
Premium access

Shareholding and investment profile for Navin Karnani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Navin Karnani

Navin Karnani currently holds 4 directorships: Deccan Nutraceuticals Private Limited (Director, since 17 Dec 2012, revenue ₹32.43 Cr (FY 2024)); Rjb Estates Private Limited (Director, since 31 Mar 2024, revenue ₹6.45 Cr (FY 2025)); Markal Industries Association (Director, since 29 Dec 2021, revenue ₹4.9 Lakh (FY 2024)); Karnani Securities Private Limited (Director, since 24 May 2025).

Navin Karnani was first appointed on 17 Dec 2012 as Director at Deccan Nutraceuticals Private Limited. The most recent appointment on record is 24 May 2025 at Karnani Securities Private Limited.

The 3 current companies of Navin Karnani that report revenue have a combined latest revenue of ₹38.93 Cr: Deccan Nutraceuticals Private Limited ₹32.43 Cr (FY 2024); Rjb Estates Private Limited ₹6.45 Cr (FY 2025); Markal Industries Association ₹4.9 Lakh (FY 2024).

Navin Karnani held 1 earlier board appointment: Smnr Exim Llp (Designated Partner, 20 Mar 2015 to 06 Aug 2024).

The current boards of Navin Karnani's companies include Megha Karnani (Deccan Nutraceuticals Private Limited), Sudhir Pancham Singh (Deccan Nutraceuticals Private Limited), Mamta Karnani (Rjb Estates Private Limited), Niraj Karnani (Rjb Estates Private Limited), Gautam Deepak Shah (Markal Industries Association), Manish Kishore Kotak (Markal Industries Association), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available